Inactive Instrument
Five Prime Therapeutics, Inc. Share Price
Stocks
FPRX
US33830X1046
Biotechnology & Medical Research
| 1 day | +0.03% |
| Manager | Title | Age | Since |
|---|---|---|---|
James Bradner
CEO | Chief Executive Officer | 53 | - |
Peter Griffith
DFI | Director of Finance/CFO | 67 | - |
Jonathan Graham
LAW | General Counsel | 65 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 16/04/21 | Issuer sale | Director | 46,250 | 0.0993% | ||
| 16/04/21 | Issuer sale | Director | 60,000 | 0.1288% | ||
| 16/04/21 | Issuer sale | Chief Executive Officer | 5,48,971 | 1.1788% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.03% | +0.16% | - | - | 174.05Cr | |
| -1.92% | -1.57% | +48.70% | +84.37% | 5.59TCr | |
| +0.93% | +6.97% | +62.83% | +67.97% | 5.67TCr | |
| -2.45% | -1.74% | -21.54% | -16.01% | 2.33TCr | |
| -0.15% | -1.56% | +3.00% | +421.14% | 2.33TCr | |
| -0.36% | -0.56% | +36.00% | -3.93% | 2.05TCr | |
| -1.34% | +0.51% | +25.02% | -30.27% | 1.78TCr | |
| -1.44% | -1.63% | +37.07% | +589.93% | 1.59TCr | |
| -1.30% | -9.92% | +160.67% | +284.37% | 1.46TCr | |
| -0.68% | -0.90% | +23.72% | +178.61% | 1.4TCr | |
| Average | -0.91% | +0.47% | +41.72% | +175.13% | 2.69TCr | |
| Weighted average by Cap. | -0.85% | +1.47% | +42.61% | +138.11% |
Employees
51
